Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Oncotarget|August 25, 2016
Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinomaLiang Hu, Ruo-Yu Wang, Jian Cai, et al.
Molecular Carcinogenesis|October 14, 2014
Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signalingYuan Yang, Ling-Hao Zhao, Bo Huang, et al.
Carcinogenesis|December 11, 2012
Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinomaLing Zhang, Fu Yang, Ji-hang Yuan, et al.
Medicine|October 9, 2015
SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving HepatectomyBei-Ge Jiang, Yuan Yang, Hui Liu, et al.
Journal of Integrative Medicine|March 20, 2013
Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trialXiao-feng Zhai, Zhe Chen, Bai Li, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N<sup>6</sup> -methyladenosine-dependent primary MicroRNA processingJin-Zhao Ma, Fu Yang, Chuan-Chuan Zhou, et al.
International Journal of Surgery (London, England)|May 13, 2018
Early enforced mobilization after liver resection: A prospective randomized controlled trialChun-Yan Ni, Zhi-Hong Wang, Zhi-Ping Huang, et al.
World Journal of Surgery|December 25, 2009
Inflammatory myofibroblastic tumor of the liver: a cohort studyLiang Tang, Eric C H Lai, Wen-Ming Cong, et al.
Journal of Molecular Evolution|April 17, 2008
Evidence of gene conversion in the evolutionary process of the codon 41/42 (-CTTT) mutation causing beta-thalassemia in southern ChinaWen Zhang, Wang-Wei Cai, Wei-Ping Zhou, et al.
Hepatobiliary Surgery and Nutrition|March 14, 2022
Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative studyPeng-Peng Li, Gang Huang, Ning-Yang Jia, et al.
Pageof 17